Prosecution Insights
Last updated: November 20, 2026
Application No. 17/813,419

SYSTEMS AND METHODS FOR TISSUE TREATMENT

Non-Final OA §103
Filed
Jul 19, 2022
Priority
Jun 11, 2012 — continuation of 9149291 +3 more
Examiner
LONG, SARAH A
Art Unit
3771
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Tenex Health Inc.
OA Round
3 (Non-Final)
61%
Grant Probability
Moderate
3-4
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 61% of resolved cases
61%
Career Allowance Rate
482 granted / 794 resolved
-9.3% vs TC avg
Strong +42% interview lift
Without
With
+42.4%
Interview Lift
resolved cases with interview
Typical timeline
4y 2m
Avg Prosecution
56 currently pending
Career history
845
Total Applications
across all art units

Statute-Specific Performance

§101
1.1%
-38.9% vs TC avg
§103
54.3%
+14.3% vs TC avg
§102
20.5%
-19.5% vs TC avg
§112
20.5%
-19.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 794 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application is being examined under the pre-AIA first to invent provisions. Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 4/22/2026 has been entered. Response to Arguments Applicant's arguments filed 4/22/2026 have been fully considered but they are not persuasive. It is noted that applicant does not agree with the priority date assessed for the claims. No new arguments are provided; therefore, the examiner maintains the previously discussed arguments found on pages 2-3 of the Final Rejection mailed 4/22/2026. Applicant argues one of ordinary skill in the art would know that the designs of Shibata et al. (US 2002/0107538 A1) are not equivalent for ultrasound delivery in the recited frequency range because Shibata notes that ultrasound delivery tends to generate vibrations and heat that can be detrimental to the device ([0028]). However, paragraph [0028] of Shibata is directed to the background of the invention i.e., problems with previous ultrasonic devices. For example, Shibata recites “If the screwing in is not done with the proper force, however, it is possible that the screw connected part will fail during use, due to vibration, just as ultrasonic vibrations are being generated, or that heat will be generated until overheating occurs.” The screwing refers to a threaded part provided in a base end of a probe (i.e., needle) into a threaded part in a horn of the handpiece ([0027]). Forming the ultrasonic vibration member 215 of a single member, and thereby fixedly coupled and made integral as taught by Shibata in paragraph [0024] would eliminate the threaded portions of the horn and the probe. Therefore, when the ultrasonic vibration member is monolithic the issues with screwing with proper force found in the background of the invention are eliminated. The primary reference Parham (US 2016/0331397 A1) discloses the horn and the needle are configured to resonate at a frequency between 25 kHz and 30 kHz ([0048]). Parham discloses wherein the needle (220) and the horn (350) are constructed as a unitary assembly ([0058]) but fails to disclose wherein the horn and the needle are monolithic. Modifying the horn and needle of Parham which resonate within the claimed frequency range to be monolithic would improve the device of Parham because the potential for the connection between the horn and needle to fail during use would be eliminated. Accordingly, applicants over Parham and Shibata are not found persuasive. Priority Applicant’s claim for the benefit of a prior-filed application under 35 U.S.C. 119(e) or under 35 U.S.C. 120, 121, 365(c), or 386(c) is acknowledged. Applicant has not complied with one or more conditions for receiving the benefit of an earlier filing date under 35 U.S.C. 35 U.S.C. 119(e) or under 35 U.S.C. 120, 121, 365(c), or 386(c) as follows: The later-filed application must be an application for a patent for an invention which is also disclosed in the prior application (the parent or original nonprovisional application or provisional application). The disclosure of the invention in the parent application and in the later-filed application must be sufficient to comply with the requirements of 35 U.S.C. 112(a) or the first paragraph of pre-AIA 35 U.S.C. 112, except for the best mode requirement. See Transco Products, Inc. v. Performance Contracting, Inc., 38 F.3d 551, 32 USPQ2d 1077 (Fed. Cir. 1994). The disclosure of the prior-filed application, Application Nos. 13/493,851, 14/866,472, and 15/716,278, fail to provide adequate support or enablement in the manner provided by 35 U.S.C. 112(a) or pre-AIA 35 U.S.C. 112, first paragraph for one or more claims of this application. For example, the prior-filed applications fail to provide support for “a hardened stainless steel needle; wherein the horn and the needle are monolithic”. Accordingly, the present application has been given an effective filing date of 11/21/2019. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of pre-AIA 35 U.S.C. 103(a) which forms the basis for all obviousness rejections set forth in this Office action: (a) A patent may not be obtained though the invention is not identically disclosed or described as set forth in section 102, if the differences between the subject matter sought to be patented and the prior art are such that the subject matter as a whole would have been obvious at the time the invention was made to a person having ordinary skill in the art to which said subject matter pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under pre-AIA 35 U.S.C. 103(a) are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim(s) 1, 3 and 9-11 is/are rejected under pre-AIA 35 U.S.C. 103(a) as being unpatentable over Parham (US 2016/0331397 A1) in view of Shibata et al. (US 2002/0107538 A1). Regarding claim 1, Parham discloses an ultrasonic energy delivery device (ultrasonic deliver device 100; Figs. 1-3) configured to deliver ultrasonic energy to a musculoskeletal tissue site (targets can include musculoskeletal tissues such as bone; [0063]), the device comprising: a horn (horn 350) configured to receive energy generated by a transducer (as the needle transmits ultrasonic energy via the horn and ultrasonic handpiece; [0018]); and a hardened stainless steel needle (needle 220 made of a work hardened stainless steel; [0009]); wherein the horn and the needle are configured to resonate at a frequency between 25 kHz and 30 kHz (a desirable ultrasonic frequency range includes frequencies between about 25-35 kHz; [0048]). Parham discloses wherein the needle (220) and the horn (350) are constructed as a unitary assembly ([0058]) but fails to disclose wherein the horn and the needle are monolithic. However, Shibata teaches an ultrasonic energy delivery device (Figs. 17A-17D) comprising a horn (horn 213) and a needle (ultrasonic vibration transmission member 215) in which the horn and the needle can be made separately and fixedly connected to one another (Figs. 17A-17C) or, alternatively, where the horn and the needle can be formed of a single member (Fig. 17D; [0224]) i.e., are monolithic. It would have been obvious to one of ordinary skill in the art at the time the invention was made to modify the horn and needle of Parham to be monolithic as taught by Shibata. All the claimed elements were known in the prior art and one skilled in the art could have combined the elements as claimed by known methods with no change in their respective functions, and the combination would have yielded the predictable result of achieving a unitary, integral, fixedly secured needle and horn assembly for an ultrasonic energy delivery device. Further, modifying the horn and needle of Parham to be monolithic reduces the potential for the connection between the horn and needle to fail during use. Regarding claim 3, Parham modified discloses the invention as claimed above, and Parham further discloses wherein the needle (220) comprises a work-hardened stainless steel needle ([0009]) which is found equivalent to the claimed “precipitation-hardened stainless steel” as both are heat treated. Regarding claim 9, Parham modified discloses the invention as claimed above, and Parham further discloses wherein the frequency is 26.5 kHz (a desirable ultrasonic frequency range includes frequences between about 25-30 kHz, which includes the claimed range; [0048). Regarding claims 10-11, Parham modified discloses the invention as claimed above, and Parham further discloses wherein the needle comprises an insertion length of 0.25 to 3 inches and/or 1.3 to 3 inches (the length of the portion of the needle that extends beyond the horn is between about 1.5 and 2.2 inches; [0007]). Claim(s) 2, 4-5, 8 and 12-14 is/are rejected under pre-AIA 35 U.S.C. 103(a) as being unpatentable over Parham (US 2016/0331397 A1) in view of Shibata et al. (US 2002/0107538 A1) in view of Frankhouser et al. (US 2012/0209303 A1). Regarding claim 2, modified Parham fails to disclose a processor configured to activate the transducer, wherein the processor includes stored instructions that when executed cause the device to deliver ultrasonic energy at a frequency selected to debride the musculoskeletal tissue. However, Frankhouser teaches an ultrasonic energy device (202) comprising a processor to activate the transducer ([0204]), wherein the processor includes stored instructions that when executed cause the device to delivery ultrasonic energy at a frequency selected to debride the musculoskeletal tissue ([0196]). It would have been obvious to one having ordinary skill in the art at the time the invention was made to combine the stored instructions on the processor as taught by Frankhouser with the device of modified Parham because it allows the user to track whether the real time data matches the expected data stored on the processor and allows the device to automatically adjust the resonant frequency as needed (Frankhouser, [0196-0197]). The motivation for the modification is to automatically update the particular parameters of the device (Frankhouser, [0204]). Regarding claim 4, Parham discloses a system configured to deliver ultrasonic energy to a musculoskeletal tissue site (targets can include musculoskeletal tissues such as bone; [0063]), the system comprising: a delivery device (ultrasonic delivery device 100; Figs. 1-3), the device comprising: a horn (horn 350); and a hardened stainless steel needle (needle 220 made of a work hardened stainless steel; [0009]); wherein the horn and the needle are configured to resonate at a resonating frequency between 25 kHz and 30 kHz (a desirable ultrasonic frequency range includes frequencies between about 25-35 kHz; [0048]). Parham discloses wherein the needle (220) and the horn (350) are constructed as a unitary assembly ([0058]) but fails to disclose wherein the horn and the needle are monolithic; and a memory device containing instructions; a processor in communication with the memory device; wherein execution of the instructions by the processor causes a transducer to generate ultrasonic energy at a pre-determined frequency suitable for debriding musculoskeletal tissue. However, Shibata teaches an ultrasonic energy delivery device (Figs. 17A-17D) comprising a horn (horn 213) and a needle (ultrasonic vibration transmission member 215) in which the horn and the needle can be made separately and fixedly connected to one another (Figs. 17A-17C) or, alternatively, where the horn and the needle can be formed of a single member (Fig. 17D; [0224]) i.e., are monolithic. It would have been obvious to one of ordinary skill in the art at the time the invention was made to modify the horn and needle of Parham to be monolithic as taught by Shibata. All the claimed elements were known in the prior art and one skilled in the art could have combined the elements as claimed by known methods with no change in their respective functions, and the combination would have yielded the predictable result of achieving a unitary, integral, fixedly secured needle and horn assembly for an ultrasonic energy delivery device. Further, modifying the horn and needle of Parham to be monolithic reduces the potential for the connection between the horn and needle to fail during use. Modified Parham fails to disclose a memory device containing instructions; a processor in communication with the memory device; and wherein execution of the instructions by the processor causes a transducer to generate ultrasonic energy at a pre-determined frequency suitable for debriding musculoskeletal tissue. However, Frankhouser discloses an ultrasonic energy device (202) comprising memory device containing instructions (stored values in a memory; [0196]); a processor in communication with the memory device ([0196]), wherein execution of the instructions by the processor causes a transducer to generate ultrasonic energy ([0240]) at a pre-determined frequency suitable for debriding musculoskeletal tissue ([0196]). It would have been obvious to one having ordinary skill in the art at the time the invention was made to combine the stored instructions on the memory device of the processor as taught by Frankhouser with the device of modified Parham because it allows the user to track whether the real time data matches the expected data stored on the processor and allows the device to automatically adjust the resonant frequency as needed (Frankhouser, [0196-0197]). The motivation for the modification is to automatically update the particular parameters of the device (Frankhouser, [0204]). Regarding claim 5, modified Parham discloses the invention as claimed above, and Parham further discloses a fluid source (as fluid is transported between needle 220 and sheath 230 either in or out of the needle; [0036]-[0037]), wherein the delivery device further comprises a fluid delivery conduit (conduit between needle 220 and sheath 230) for delivering fluid from the fluid source to the musculoskeletal tissue site ([0036]). Regarding claim 8, Parham modified discloses the invention as claimed above, and Parham further discloses wherein the needle (220) comprises a work-hardened stainless steel needle ([0009]) which is found equivalent to the claimed “precipitation-hardened stainless steel” as both are heat treated. Regarding claim 12, Parham modified discloses the invention as claimed above, and Parham further discloses wherein the resonating frequency is 26.5 kHz (a desirable ultrasonic frequency range includes frequences between about 25-30 kHz, which includes the claimed range; [0048). Regarding claims 13-14, Parham modified discloses the invention as claimed above, and Parham further discloses wherein the needle comprises an insertion length of 0.25 to 3 inches and/or 1.3 to 3 inches (the length of the portion of the needle that extends beyond the horn is between about 1.5 and 2.2 inches; [0007]). Claim(s) 6 is/are rejected under pre-AIA 35 U.S.C. 103(a) as being unpatentable over Parham (US 2016/0331397 A1) in view of Shibata et al. (US 2002/0107538 A1) in view of Frankhouser et al. (US 2012/0209303 A1), as applied to claim 4 above, and further in view of Wiksell (US 4,886,060). Regarding claim 6, modified Parham fails to explicitly disclose wherein the delivery device further comprises an aspiration conduit configured to remove detritus from the musculoskeletal site. However, Wiksell teaches an ultrasonic delivery device (abstract; Fig. 2) comprising a horn (at 7) and needle (distal end of 7; Fig. 2), wherein the needle and horn include an aspiration conduit (bore 6) configured to aspirate (column 3, lines 66-68). It would have been obvious to one of ordinary skill in the art at the time the invention was made to modify the delivery device of modified Parham to include an aspiration conduit configured to remove detritus from the musculoskeletal site in light of the teachings of Wiksell in order to remove fluid and debris from the target treatment site. Claim(s) 7 is/are rejected under pre-AIA 35 U.S.C. 103(a) as being unpatentable over Parham (US 2016/0331397 A1) in view of Shibata et al. (US 2002/0107538 A1) in view of Frankhouser et al. (US 2012/0209303 A1), as applied to claim 4 above, and further in view of Desinger (US 2002/0007200). Regarding claim 7, modified Parham fails to disclose wherein the delivery device includes a housing having a clear portion. However, Desinger teaches an ultrasonic energy delivery system comprising a housing (14) having a clear portion ([0033]; “transparent”). It would have been obvious to one of ordinary skill in the art at the time the invention was made to combine the housing comprising a clear portion as taught by Desinger with the system of modified Parham because it allows for an interior view of the housing (Desinger, [0033]). The motivation for the modification would have been to allow the user to see inside the housing to determine if the device needs cleaning or repair without having to open the housing. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to SARAH A LONG whose telephone number is (571)270-3865. The examiner can normally be reached Monday-Friday 9am-5pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Elizabeth Houston can be reached on (571)272-7134. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /SARAH A LONG/Primary Examiner, Art Unit 3771
Read full office action

Prosecution Timeline

Jul 19, 2022
Application Filed
Feb 26, 2025
Non-Final Rejection mailed — §103
Aug 26, 2025
Response Filed
Oct 23, 2025
Final Rejection mailed — §103
Apr 22, 2026
Request for Continued Examination
Apr 27, 2026
Response after Non-Final Action
May 18, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12797106
ULTRASONIC SURGICAL INSTRUMENT AND PROCESSING AND ASSEMBLING METHOD
3y 1m to grant Granted Nov 17, 2026
Patent 12797580
MEDICAL INSTRUMENT WITH DUAL-OUTPUT, SINGLE-INPUT DRIVE ASSEMBLY
2y 0m to grant Granted Nov 17, 2026
Patent 12788395
APPARATUS FOR CLOSING A SURGICAL SITE
1y 9m to grant Granted Nov 10, 2026
Patent 12773217
Left Atrial Appendage Clipping Device and Methods for Clipping the LAA
3y 4m to grant Granted Oct 27, 2026
Patent 12773289
ARTICULATED TOOL POSITIONER FOR ROBOTIC SURGERY SYSTEM
2y 0m to grant Granted Oct 27, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
61%
Grant Probability
99%
With Interview (+42.4%)
4y 2m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 794 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month